NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Life Insurance Corporation of India (LIC) Investment Update

As of February 2026, LIC has reported a significant decline in its investment in IT stocks, valued at Rs 42,500 crore over the past two months. This erosion in value can be attributed to the downturn in the IT sector, primarily driven by concerns over artificial intelligence disruption.

LIC has witnessed substantial value loss in Infosys and Tata Consultancy Services, with a total decline of Rs 26,510 crore. This decline is a notable aspect of the LIC's overall equity portfolio performance.

As of December 31, 2025, the LIC's equity portfolio stood at Rs 17.83 lakh crore, according to exchange data. Notably, 12.43% of its equity portfolio, amounting to Rs 2.17 lakh crore, was allocated to the IT sector.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Investor Takeaway

Investors should be cautious of the IT sector's decline due to AI disruption fears.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.